Literature DB >> 29221252

Pure ground-glass nodules: are they really indolent?

Julien G Cohen1,2, Gilbert R Ferretti1,2.   

Abstract

Year:  2017        PMID： 29221252      PMCID： PMC5708492          DOI： 10.21037/jtd.2017.08.89

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Volume-doubling time of pulmonary nodules with ground glass opacity at multidetector CT: Assessment with computer-aided three-dimensional volumetry.

Authors:  Seitaro Oda; Kazuo Awai; Kohei Murao; Akio Ozawa; Daisuke Utsunomiya; Yumi Yanaga; Koichi Kawanaka; Yasuyuki Yamashita
Journal:  Acad Radiol       Date:  2011-01       Impact factor: 3.173

2.  CT characteristics and pathological implications of early stage (T1N0M0) lung adenocarcinoma with pure ground-glass opacity.

Authors:  Xin Jin; Shao-hong Zhao; Jie Gao; Dian-jun Wang; Jian Wu; Chong-chong Wu; Rui-ping Chang; Hai-yue Ju
Journal:  Eur Radiol       Date:  2015-03-01       Impact factor: 5.315

3.  Software performance in segmenting ground-glass and solid components of subsolid nodules in pulmonary adenocarcinomas.

Authors:  Julien G Cohen; Jin Mo Goo; Roh-Eul Yoo; Chang Min Park; Chang Hyun Lee; Bram van Ginneken; Doo Hyun Chung; Young Tae Kim
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

4.  Persistent Pure Ground-Glass Nodules Larger Than 5 mm: Differentiation of Invasive Pulmonary Adenocarcinomas From Preinvasive Lesions or Minimally Invasive Adenocarcinomas Using Texture Analysis.

Authors:  In-Pyeong Hwang; Chang Min Park; Sang Joon Park; Sang Min Lee; Holman Page McAdams; Yoon Kyung Jeon; Jin Mo Goo
Journal:  Invest Radiol       Date:  2015-11       Impact factor: 6.016

5.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim Geisinger; Yasushi Yatabe; Charles A Powell; David Beer; Greg Riely; Kavita Garg; John H M Austin; Valerie W Rusch; Fred R Hirsch; James Jett; Pan-Chyr Yang; Michael Gould
Journal:  Proc Am Thorac Soc       Date:  2011-09

6.  Lung cancers diagnosed at annual CT screening: volume doubling times.

Authors:  Claudia I Henschke; David F Yankelevitz; Rowena Yip; Anthony P Reeves; Ali Farooqi; Dongming Xu; James P Smith; Daniel M Libby; Mark W Pasmantier; Olli S Miettinen
Journal:  Radiology       Date:  2012-03-27       Impact factor: 11.105

7.  Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and Size.

Authors:  Benedikt H Heidinger; Kevin R Anderson; Ursula Nemec; Daniel B Costa; Sidhu P Gangadharan; Paul A VanderLaan; Alexander A Bankier
Journal:  J Thorac Oncol       Date:  2017-05-30       Impact factor: 15.609

8.  [New WHO classification of lung adenocarcinoma and preneoplasia].

Authors:  Sylvie Lantuejoul; Isabelle Rouquette; Elisabeth Brambilla; William D Travis
Journal:  Ann Pathol       Date:  2016-01-11       Impact factor: 0.407

9.  Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications.

Authors:  Hyun-Ju Lim; Soomin Ahn; Kyung Soo Lee; Joungho Han; Young Mog Shim; Sookyoung Woo; Jae-Hun Kim; Miyeon Yie; Ho Yun Lee; Chin A Yi
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

10.  CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.

Authors:  L Felix; G Serra-Tosio; S Lantuejoul; J F Timsit; D Moro-Sibilot; C Brambilla; G R Ferretti
Journal:  Eur J Radiol       Date:  2009-10-04       Impact factor: 3.528
View more
  1 in total

1.  Morphologic characteristics of pulmonary adenocarcinomas manifesting as pure ground-glass nodules on CT.

Authors:  Benedikt H Heidinger; Kevin R Anderson; Ursula Nemec; Daniel B Costa; Sidhu P Gangadharan; Paul A VanderLaan; Alexander A Bankier
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.